These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 27933713)

  • 1. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study.
    Hochman E; Krivoy A; Schaffer A; Weizman A; Valevski A
    Bipolar Disord; 2016 Dec; 18(8):684-691. PubMed ID: 27933713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates.
    Shvartzman Y; Krivoy A; Valevski A; Gur S; Weizman A; Hochman E
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):353-360. PubMed ID: 29449055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
    J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
    Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
    Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
    Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.
    Valdes M; Bertolin S; Qian H; Wong H; Lam RW; Yatham LN
    J Affect Disord; 2019 Mar; 246():861-866. PubMed ID: 30795492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid personality disorders in manic bipolar I disorder patients is associated with increased use of long-acting injectable antipsychotic treatment and higher rates of rehospitalization.
    Goren Y; Krivoy A; Gur S; Valevski A; Weizman A; Hochman E
    Int Clin Psychopharmacol; 2020 Mar; 35(2):74-80. PubMed ID: 31764217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder.
    Bauer MS; Miller CJ; Li M; Bajor LA; Lee A
    Bipolar Disord; 2016 Sep; 18(6):481-489. PubMed ID: 27650468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study.
    Wingård L; Brandt L; Bodén R; Kieler H; Andersen M; Reutfors J
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):691-700. PubMed ID: 31078359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics.
    Lin CH; Huang CW; Chen CC; Hsu YF; Chang WH; Lane HY
    Psychopharmacology (Berl); 2008 Oct; 200(2):301-3. PubMed ID: 18566801
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
    Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic.
    Patel NC; Crismon ML; Pondrom M
    J Behav Health Serv Res; 2005; 32(4):438-45. PubMed ID: 16215452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.